Cyberounds Logo
September 23, 2020 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
The Role of Angiotensin Receptor Blockade in the Treatment of Heart Failure
CME credit is no longer available for this conference.
Frank A. Laws, M.D., and Richard W. Smalling, M.D., Ph.D.

Dr. Laws is a Fellow in the Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Medical School.

Dr. Laws reports no commercial conflict of interest. Dr. Smalling has received grant/research support from Centocor/Boston Scientific within the last three years.

This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.


Release Date: 01/03/2000
Termination Date: 01/03/2003

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Identify why blockade of the renin-angiotensin aldosterone system (RAAS) confers a beneficial effect in patients with congestive heart failure
  • Identify pathways involved in the production of angiotensin-II and receptors that mediate the effects of angiotensin-II
  • List the objectives of ongoing clinical trials assessing the role of ARBs in the treatment of patients with congestive heart failure.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity